Showing 1 - 14 results of 14 for search 'L S Al'-Radi', query time: 0.03s
Refine Results
-
1
Treatment for recurrent hairy cell leukemia. by L S Al'-Radi, A V Pivnik, B V Zingerman, S K Kravchenko
Published 2012-07-01
Article -
2
-
3
-
4
-
5
-
6
P019: Unfavorable prognostic value of the predominance of THRLBCL-like histopathological growth patterns in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) by Elena Dorokhina, T.N. Moiseeva, A.M. Kovrigina, Irirna Shupletsova, L.S. Al-Radi, Yu. A. Chabaeva, Ya.K. Mangasarova
Published 2022-10-01
Article -
7
HEPARIN-INDUCED THROMBOCYTOPENIA (REVIEW) by S. A. Vasiliev, L. A. Gorgidze, T. N. Moiseeva, L. S. Al’-Radi, N. I. Zozulya, M. A. Sokolova, A. V. Mazurov
Published 2019-06-01
Article -
8
P007: Comparative efficacy of the R-BEACOPP-14 and R-CHOP regimens in the treatment of patients with advanced stages of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with... by Elena Dorokhina, T.N. Moiseeva, A.M. Kovrigina, Irirna Shupletsova, L.S. Al-Radi, Yu. A. Chabaeva, Ya.K. Mangasarova
Published 2022-10-01
Article -
9
-
10
-
11
Determination of morphology and immunophenotype of circulating lymphoma cells in patients with splenic marginal zone lymphoma using an anti-CD antibody microarray by A. N. Khvastunova, L. S. Al-Radi, O. S. Fedyanina, U. L. Julhakyan, N. M. Kapranov, A. O. Zakirova, S. A. Lugovskaya, E. V. Naumova, F. I. Ataullakhanov, S. A. Kuznetsova
Published 2017-04-01
Article -
12
Cell-binding microarray application in diagnosis of hairy cell leukemia by A. N. Khvastunova, L. S. Al-Radi, N. M. Kapranov, O. S. Fedyanina, L. A. Gorgidze, S. A. Lugovskaya, E. V. Naumova, U. L. Dzhulakyan, A. V. Filatov, F. I. Ataullakhanov, S. A. Kuznetsova
Published 2015-06-01
Article -
13
Cell-binding microarray application in diagnosis of hairy cell leukemia by A. N. Khvastunova, L. S. Al-Radi, N. M. Kapranov, O. S. Fedyanina, L. A. Gorgidze, S. A. Lugovskaya, E. V. Naumova, U. L. Dzhulakyan, A. V. Filatov, F. I. Ataullakhanov, S. A. Kuznetsova
Published 2015-06-01
Article -
14
P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin’s lymphoma. by Ya.K. Mangasarova, T.N. Moiseeva, L.S. Al-Radi, O.V. Margolin, L.G. Gorenkova, E.S. Nesterova, M.O. Bagova, E.A. Fastova, R.R. Abdurashidova, Z.T. Sarakaeva, Elena Dorokhina, S.K. Kravchenko, A.U. Magomedova, E.E. Zvonkov
Published 2022-10-01
Article